Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$17,332,964
+$7,720,448 QoQ
Shares Held
14,451
+38.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#959
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fisher Funds Management LTD holds $113,929,881 across 7 Drug Manufacturers - General names. LLY ranks #4 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
110,089 | $27,959,303 | |
| 2 | ABBV |
AbbVie Inc.
|
99,740 | $25,098,573 | |
| 3 | MRK |
Merck & Co., Inc.
|
151,132 | $19,420,462 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
14,451 | $17,332,964 | |
| 5 | AMGN |
Amgen Inc
|
24,245 | $8,779,599 | |
| 6 | PFE |
Pfizer Inc
|
324,451 | $7,812,780 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
59,571 | $7,526,200 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,332,964 | 14,451 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $9,612,516 | 10,451 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $11,231,481 | 10,451 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $7,974,113 | 10,451 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $8,146,868 | 10,451 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $9,590,466 | 11,612 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,964,464 | 11,612 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||